From: Characterization of the human gut virome in metabolic and autoimmune diseases
Disease | Study population | References |
---|---|---|
IA | children with high-risk HLA genotypes who seroconverted (n= 19, 18) and matched controls in Finland | |
IA | children with high-risk HLA genotypes who seroconverted (n= 11) and matched controls in Finland and Estonia | [50] |
IA/T1DM | children with high-risk HLA genotypes (n= 10: seroconverted, n= 6; progressed to T1DM, n= 4) and non-seroconverted control individuals (n= 8) in Finland and Estonia | [51] |
At risk for RA | FDRs of individuals with RA (n= 16: with anti-CCP antibodies, n= 8; without anti-CCP antibodies, n= 8) and healthy matched controls (n= 9) in the United States | [52] |
RA, SLE, MS | patients with RA (n= 111), SLE (n= 47), MS (n= 29) and healthy controls (n= 289) in Japan | [53] |